Showing results (31-40 of 452) with videos related to
Sort By:
Pageof 46
Current Radiopharmaceuticals|October 18, 2016
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for MelanomaXimena Camacho, Victoria Calzada, Marcelo Fernandez, et al.Current Radiopharmaceuticals|September 19, 2019
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin AnalogueVictoria Trindade, Henia BalterCurrent Radiopharmaceuticals|June 26, 2012
Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imagingXiuli Zhang, Zhiwei Yue, Bao-Yuan Lu, et al.Current Radiopharmaceuticals|June 26, 2012
Synthesis of a potent cathepsin s inhibitor labeled with deuterium and carbon-14Bachir Latli, Matt Hrapchak, Jon C Lorenz, et al.Current Radiopharmaceuticals|October 24, 2024
Apigenin's Influence on Inflammatory and Epigenetic Responses in Rat Lungs After RadiotherapyFatemeh Rajabinasab, Pooya Hajimirzaei, Fatemeh Ramezani, et al.Current Radiopharmaceuticals|March 4, 2025
The Central Composite Design and Artificial Neural Network Coupled with Genetic Algorithm in Optimization and Modeling of the Radiolabeling Process of 177Lu-hydroxyapatite as a Potential Radiosynovectomy AgentSima Attar Nosrati, Maryam Salahinejad, Mohammad Reza Aboudzadeh, et al.Current Radiopharmaceuticals|February 27, 2025
A New Approach to Synthesizing Carbon-11-PBR28 and its Clinical Validation in ALS PatientsPardeep Kumar, Aishwarya Kumar, Muddasu Keerthipriya, et al.Current Radiopharmaceuticals|February 18, 2025
Dilemma on Pancreatic Uncinate Process Uptake on Ga68-DOTA Peptide PET/CT in Pediatric Neuroblastoma: Physiologic or Metastases?Nedim C M Gülaldi, Nadide Basak Gülleroglu, Selma Cakmakci, et al.Current Radiopharmaceuticals|February 13, 2025
Mitigation of Radiation-induced Acute Hematopoietic System and Intestine Injury by Resveratrol-loaded Polymeric Nanoparticles after Whole Body Irradiation in MiceMohammad Mohammadi, Amir Kiani, Faranak Aghaz, et al.Current Radiopharmaceuticals|September 10, 2024
Left Ventricular Wall Motion as an Additional Valuable Parameter in Diabetic Patients with Normal Myocardial Perfusion ImagingAmirhesam Davari, Fatemeh Jalali-Zefrei, Bahare Gholami-Chabok, et al.Pageof 46